Pharmaceutical drug delivery refers to the methods and technologies used to administer medications to patients in order to achieve therapeutic effects. The goal of drug delivery systems is to enhance the efficiency, safety, and convenience of drug administration, while also improving patient compliance and minimizing side effects.
The pharmaceutical drug delivery market plays a critical role in the healthcare industry by enabling the efficient and targeted administration of medications to patients. It encompasses a wide range of technologies and approaches designed to optimize drug absorption, distribution, metabolism, and excretion, ultimately enhancing therapeutic outcomes while minimizing side effects. Over the years, significant advancements have been made in drug delivery systems, addressing various challenges associated with traditional methods of drug administration. These challenges include poor bioavailability, rapid clearance from the body, patient compliance issues, and the need for frequent dosing.
Ask Us to Get Your Sample Copy Of The Report, Covering TOC and Regional Analysis @
Top Companies Associated With The Pharmaceutical Drug Delivery Market Report Are:
Key players operating in the global pharmaceutical drug delivery market include Johnson and Johnson, Merck & Co, Inc., Bayer AG, Pfizer, Inc., Novartis AG, Sanofi, Antares Pharma, Inc., Accord Healthcare, Inc., Abbott, and GSK.
Global Pharmaceutical drug Delivery Market Drivers
The growth of the worldwide pharmaceutical drug delivery market is anticipated to be propelled by the increasing approval rates of novel drugs by the U.S. FDA. An illustrative example is the approval granted in April 2019 by the U.S. Food and Drug Administration to Duobrii, a product containing halobetasol propionate and tazarotene. This medication is utilized for treating plaque psoriasis and is manufactured by Ortho Dermatologics Company.
Moreover, the global pharmaceutical drug delivery market is poised to receive a boost from the introduction of new products. A case in point is Sanofi Genzyme’s launch of the drug Aubagio in August 2018, designed for addressing multiple sclerosis. Offering a once-daily treatment regimen, Aubagio enhances patient convenience.
Additionally, Pfizer made a significant contribution to the market by introducing trastuzumab (marketed as trazimera) in April 2019. This drug is aimed at treating metastatic HER2-positive breast cancer and HER2-positive metastatic gastric cancer. As a result, these innovative products are anticipated to invigorate the global pharmaceutical drug delivery market.
Global Pharmaceutical drug Delivery Market-Taxonomy
By Route of Administration
- Oral Drug Delivery
- Solid Oral Drugs
- Liquid Oral Drugs
- Semi-Solid Oral Drugs
- Topical Drug Delivery
- Liquid Formulation
- Semi-Solid Formulation
- Solid Formulation
- Transdermal Products
- Pulmonary Drug Delivery
- Metered-Dose Inhalers
- Dry Powder Inhalers
- Nasal Drug Delivery
- Nasal Drops
- Nasal Sprays
- Nasal Powders
- Nasal Gels
- Transmucosal Drug Delivery
- Oral Formulations
- Injectable Drug Delivery
- Conventional Injection Devices
- Self-Injection Devices
- Ocular Drug Delivery
- Liquid Formulations
- Semi-Solid Formulations
- Ocular Devices
- Implantable Drug Delivery
- Active Implantable Drug Delivery
- Passive Implantable Drug Delivery
- Infectious Diseases
- Cardiovascular Diseases
- Respiratory Diseases
- Central Nervous System Disorders
- Autoimmune Diseases
By End User
- Ambulatory Surgical Centers/ Clinics
- Diagnostic Centers
Global Pharmaceutical Drug Delivery Market Restraints
Anticipated hindrances to the expansion of the worldwide pharmaceutical drug delivery market include shortages of medications. As illustrated, a February 2019 report from The New York Times highlighted a scarcity of Buspirone HCL Tablets – 7.5mg, produced by Accord Healthcare Inc., attributable to heightened demand for this anxiety treatment drug.
Furthermore, in September 2018, the Union Health Ministry of India imposed a ban on 328 FDC (Fixed Dose Composition) drugs due to the irrational utilization of such combinations. Notable examples of the prohibited drugs encompass Aceclofenac (SR) + Paracetamol 750, Aceclofenac + Paracetamol + Famotidine, and naproxen plus paracetamol. The prohibition of these drugs is poised to exert an impact on the progress of the global pharmaceutical drug delivery market.
Purchase This Premium Report And Get Up To 25 % Off @
Global Pharmaceutical Drug Delivery Market- Regional Analysis
Table of Contents with Major Points:
- Key Findings
- Definitions and Assumptions
- Definition of Pharmaceutical Drug Delivery Market
- Market Dynamics
- Trends and Developments
- Key Emerging Trends
- Key Developments Mergers and Acquisition
- New Product Launches and Collaboration
- Partnership and Joint Venture
- Latest Technological Advancements
- Insights on Regulatory Scenario
- Porters Five Forces Analysis
Qualitative Insights Impact of COVID-19 on Global Pharmaceutical Drug Delivery Market
- Supply Chain Challenges
- Steps taken by Government/Companies to overcome this impact
- Potential opportunities due to COVID-19 outbreak
- Data Sources
We Offer Customized Report, Click @
Why Choose Coherent Market Insights?
☛ Identified business opportunities – Our market research report can be used to analyze potential markets and new products. It can give information about customer needs, preferences, and attitudes. Also, it compare products and services.
☛ A clear understanding of your customers – A market report gives company’s marketing department an in-depth picture about customers’ needs and wants. This knowledge can be used to improve products, prices, and advertising.
☛ Clear data-driven insights – Our Market research encompasses a wide range of activities, from determining market size and segment to forecasting demand, and from identifying competitors to monitoring pricing. All of these are quantified and measurable which means that gives you a clear path for building unique decisions based on numbers.
Explore More Related Insights:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Senior Client Partner – Business Development
Coherent Market Insights
Follow Us: LinkedIn | Twitter